relative to prohibiting discriminatory actions related to participation in the federal 340B Drug Pricing Program.

This New Hampshire bill prohibits health insurance companies, pharmacy benefit managers, and other payers from treating entities differently because they participate in the federal 340B Drug Pricing Program. Specifically, the law forbids these payers from imposing stricter network rules or lower reimbursement rates for drugs covered under the program compared to those offered to other providers. The measure directly affects hospitals and clinics that use the 340B program to purchase discounted medications, ensuring they face the same terms as other healthcare entities. By banning discrimination based on this specific federal participation, the bill aims to maintain equal access to reimbursement and network participation for all covered entities in the state.